News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,406 Results
Type
Article (48587)
Company Profile (319)
Press Release (705478)
Multimedia
Podcasts (117)
Webinars (24)
Section
Business (210005)
Career Advice (2218)
Deals (36205)
Drug Delivery (151)
Drug Development (82900)
Employer Resources (197)
FDA (16717)
Job Trends (15389)
News (354466)
Policy (33494)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2786)
Academic (2)
Accelerated approval (48)
Adcomms (30)
Allergies (173)
Alliances (51163)
ALS (216)
Alzheimer's disease (1856)
Antibody-drug conjugate (ADC) (469)
Approvals (17095)
Artificial intelligence (714)
Autoimmune disease (302)
Automation (57)
Bankruptcy (368)
Best Places to Work (11827)
BIOSECURE Act (21)
Biosimilars (225)
Biotechnology (195)
Bladder cancer (198)
Brain cancer (72)
Breast cancer (768)
Cancer (5952)
Cardiovascular disease (484)
Career advice (1892)
Career pathing (48)
CAR-T (349)
CDC (63)
Celiac Disease (3)
Cell therapy (944)
Cervical cancer (48)
Clinical research (71725)
Collaboration (2145)
Company closure (5)
Compensation (1412)
Complete response letters (82)
COVID-19 (2825)
CRISPR (112)
C-suite (1182)
Cystic fibrosis (153)
Data (8070)
Decentralized trials (3)
Denatured (46)
Depression (165)
Dermatology (87)
Diabetes (593)
Diagnostics (7101)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (344)
Drug pricing (212)
Drug shortages (32)
Duchenne muscular dystrophy (292)
Earnings (93057)
Editorial (70)
Employer branding (25)
Employer resources (167)
Events (123392)
Executive appointments (1120)
FDA (20499)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1795)
Gene editing (245)
Generative AI (61)
Gene therapy (752)
GLP-1 (1107)
Government (4903)
Grass and pollen (6)
Guidances (409)
Healthcare (19405)
HIV (82)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (298)
Immuno-oncology (94)
Indications (196)
Infectious disease (3173)
Inflammatory bowel disease (224)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (297)
Interviews (353)
IPO (16882)
IRA (52)
Job creations (3859)
Job search strategy (1580)
JPM (62)
Kidney cancer (19)
Labor market (111)
Layoffs (592)
Leadership (44)
Legal (8116)
Liver cancer (101)
Longevity (32)
Lung cancer (786)
Lymphoma (435)
Machine learning (62)
Management (63)
Manufacturing (1084)
MASH (195)
Medical device (14107)
Medtech (14237)
Mergers & acquisitions (20585)
Metabolic disorders (1542)
mRNA (220)
Multiple sclerosis (191)
NASH (23)
Neurodegenerative disease (436)
Neuropsychiatric disorders (107)
Neuroscience (3410)
Neurotech (1)
NextGen: Class of 2026 (6725)
Non-profit (4701)
Now hiring (79)
Obesity (729)
Opinion (313)
Ovarian cancer (230)
Pain (265)
Pancreatic cancer (311)
Parkinson's disease (372)
Partnered (35)
Patents (605)
Patient recruitment (682)
Peanut (64)
People (61723)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (22369)
Phase 2 (31580)
Phase 3 (23487)
Pipeline (8961)
Policy (338)
Postmarket research (2650)
Preclinical (9761)
Press Release (72)
Prostate cancer (310)
Psychedelics (57)
Radiopharmaceuticals (332)
Rare diseases (1104)
Real estate (6296)
Recruiting (77)
Regulatory (25942)
Reports (72)
Research institute (2576)
Resumes & cover letters (378)
Rett syndrome (39)
RNA editing (23)
RSV (90)
Schizophrenia (183)
Series A (303)
Series B (220)
Service/supplier (13)
Sickle cell disease (117)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3848)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (87)
The Weekly (69)
Vaccines (1140)
Venture capital (116)
Weight loss (474)
Women's health (130)
Worklife (22)
Date
Today (146)
Last 7 days (687)
Last 30 days (3546)
Last 365 days (30732)
2026 (13315)
2025 (30747)
2024 (35937)
2023 (40858)
2022 (51927)
2021 (56503)
2020 (54899)
2019 (47648)
2018 (35935)
2017 (33087)
2016 (32677)
2015 (38795)
2014 (32380)
2013 (27540)
2012 (29807)
2011 (30536)
2010 (29035)
Location
Africa (820)
Alabama (95)
Alaska (7)
Arizona (361)
Arkansas (15)
Asia (41437)
Australia (6868)
California (13516)
Canada (3829)
China (1376)
Colorado (580)
Connecticut (584)
Delaware (414)
Europe (90772)
Florida (2017)
Georgia (443)
Hawaii (4)
Idaho (63)
Illinois (1078)
India (92)
Indiana (617)
Iowa (24)
Japan (548)
Kansas (134)
Kentucky (52)
Louisiana (43)
Maine (76)
Maryland (1618)
Massachusetts (9725)
Michigan (389)
Minnesota (753)
Mississippi (7)
Missouri (147)
Montana (33)
Nebraska (29)
Nevada (146)
New Hampshire (86)
New Jersey (3571)
New Mexico (31)
New York (3549)
North Carolina (1758)
North Dakota (11)
Northern California (6769)
Ohio (406)
Oklahoma (24)
Oregon (42)
Pennsylvania (2709)
Puerto Rico (29)
Rhode Island (50)
South America (1188)
South Carolina (86)
South Dakota (2)
Southern California (5333)
Tennessee (217)
Texas (2172)
United States (47923)
Utah (405)
Vermont (1)
Virginia (329)
Washington D.C. (85)
Washington State (1081)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
754,406 Results for "tga sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
April 29, 2026
·
5 min read
Press Releases
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
May 6, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
May 1, 2026
·
10 min read
Press Releases
OS Therapies Schedules OST-HER2 Pharmacodynamic Response Biomarker Conference Call on April 30, 2026 at 8:30am ET
• Regulatory feedback recent from April 2026 EU EMA and Australian TGA meetings • Remaining Q2-2026 regulatory meetings include two U.S. FDA meetings and one UK MHRA meeting, in addition to follow-up meetings with EU EMA and Australian TGA
April 27, 2026
·
5 min read
Press Releases
Claritas iPET™ Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans
March 6, 2026
·
2 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Job Trends
Washington’s life sciences jobs continue increasing, up 50% from 2014-2024: report
While life sciences employment was down 0.3% nationally in 2024, it rose 1.9% in Washington, according to a new Life Science Washington report. The association’s CEO discusses the latest findings and how the state’s job market looks this year.
April 23, 2026
·
3 min read
·
Angela Gabriel
Insights
What makes life science angel investment work?
In this episode of Denatured, you’ll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a life sciences-only angel group matters, how they evaluate opportunities, and the importance of strong teams, capital efficiency and a realistic path to exit.
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
BioSyent Announces Closing of the Acquisition of Oral Science Inc.
March 2, 2026
·
3 min read
1 of 75,441
Next
